Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	1.43	0.32	0.56	0.41	1.7	8.26
Short-Term Investments	2.8	2.98	2.94	0.57	0.02	0.08
Trading Asset Securities	-	-	-	0.12	-	-
Cash & Short-Term Investments	4.23	3.3	3.5	1.1	1.72	8.34
Cash Growth	31.27%	-5.72%	217.15%	-35.97%	-79.35%	-20.20%
Receivables	6.83	6.85	7.31	6.58	6.04	5.25
Inventory	0.53	0.41	0.66	0.77	0.85	0.92
Prepaid Expenses	0.49	0.57	0.64	0.62	0.57	0.56
Other Current Assets	1.08	0.63	0.45	0.39	0.43	0.71
Total Current Assets	13.17	11.76	12.55	9.45	9.61	15.78
Property, Plant & Equipment	21.07	21.85	22.7	22.03	14.21	4.15
Long-Term Investments	-	-	-	0.31	0.31	0.31
Goodwill	1.94	1.94	1.94	1.94	1.94	1.94
Other Intangible Assets	0.83	0.86	0.92	0.99	15.15	16.21
Long-Term Deferred Tax Assets	23.62	23.62	20.8	20.49	13.74	12.01
Other Long-Term Assets	1.67	1.69	5.76	6.01	9.92	10.26
Total Assets	62.3	61.73	64.68	61.22	64.89	60.66

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Accounts Payable	2.42	2.87	1.88	3.17	1.61	1.49
Accrued Expenses	2.57	4.28	4.39	3.74	3.24	3.06
Short-Term Debt	-	2.3	3.52	1.22	2.27	-
Current Portion of Long-Term Debt	0.2	0.18	0.17	0.17	0.15	1.9
Current Portion of Leases	0.43	0.43	0.43	0.23	0.3	0.31
Current Income Taxes Payable	-	-	1.42	1.43	0.34	-
Current Unearned Revenue	9.72	9.73	9.79	9.7	9.59	9.36
Other Current Liabilities	-	-	-	1.2	1.98	4.96
Total Current Liabilities	15.33	19.79	21.6	20.86	19.48	21.07
Long-Term Debt	8.04	8.17	8.31	8.43	8.58	-
Long-Term Leases	0.15	0.47	0.51	0.85	0.31	0.61
Long-Term Unearned Revenue	54.25	50.97	46.56	41.19	36	31.27
Other Long-Term Liabilities	0.92	0.92	0.92	0.92	2.04	3.52
Total Liabilities	78.7	80.33	77.89	72.25	66.41	56.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Common Stock	0.15	0.15	0.15	0.15	0.15	0.15
Additional Paid-In Capital	45.05	44.71	44.27	43.41	42.6	41.59
Retained Earnings	-36.57	-38.44	-32.78	-31.16	-21.64	-16.74
Treasury Stock	-25.03	-25.03	-24.86	-23.43	-22.63	-20.81
Shareholders' Equity	-16.39	-18.61	-13.22	-11.03	-1.52	4.18
Total Liabilities & Equity	62.3	61.73	64.68	61.22	64.89	60.66

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Total Debt	8.82	11.56	12.93	10.9	11.61	2.82
Net Cash (Debt)	-4.59	-8.26	-9.44	-9.79	-9.89	5.52
Net Cash Growth	-	-	-	-	-	31.08%
Net Cash Per Share	-0.57	-1.02	-1.15	-1.17	-1.17	0.66
Filing Date Shares Outstanding	8.06	8.06	8.08	8.29	8.44	8.5
Total Common Shares Outstanding	8.06	8.06	8.08	8.29	8.5	8.56
Working Capital	-2.16	-8.03	-9.04	-11.41	-9.87	-5.29
Book Value Per Share	-2.03	-2.31	-1.64	-1.33	-0.18	0.49
Tangible Book Value	-19.17	-21.41	-16.08	-13.96	-18.62	-13.97
Tangible Book Value Per Share	-2.38	-2.66	-1.99	-1.68	-2.19	-1.63
Buildings	-	19.73	19.73	11.22	11.22	1.51
Machinery	-	6.03	5.97	8.75	7.74	6.84
Construction In Progress	-	-	-	6.71	-	-
Leasehold Improvements	-	1.23	1.23	1.26	1.26	1.21

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error